Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-α Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia

Author： Reed Shelby D.   Anstrom Kevin J.   Li Yanhong   Schulman Kevin A.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.5, 2008-01, pp. : 435-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Durable Molecular Complete Remission Induced by Low-dose Imatinib plus Low-dose Interferon Alpha in a Patient with Chronic Myelogenous Leukaemia

By Takeuchi J   Miura K   Hatta Y   Sawada U  

The Journal of International Medical Research, Vol. 34, Iss. 1, 2006-01 ,pp. : 103-108

Field House Publishing

Access to resources Recommend Favorite

Cost Effectiveness of Imatinib Compared with Interferon- or Hydroxycarbamide for First-Line Treatment of Chronic Myeloid Leukaemia

By Dalziel Kim   Round Ali   Garside Ruth   Stein Ken  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 515-526

Adis International

Access to resources Recommend Favorite

The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose

By Breccia Massimo   Alimena Giuliana  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2075-2087

Informa Healthcare

Access to resources Recommend Favorite

Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2375-2382

Blackwell Publishing

Access to resources Recommend Favorite

Nilotinib: In the First-Line Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia in Chronic Phase

By Garnock-Jones Karly P.  

Drugs, Vol. 71, Iss. 12, 2011-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite